To Get Help Now
Click Here
Today's Date:

Federal Judge sets Yaz Birth Control Trial Date, Accuses Bayer of Trying to “Wear Everyone Down”

AddThis Social Bookmark Button

Judge sets Yaz Birth Control Trial Date

Judge sets Yaz Birth Control Trial Date

An Illinois federal judge overseeing the Yaz birth control multidistrict litigation (MDL) set a trial date on Friday for one of the suits in the litigation.

The MDL involves allegations that Bayer HealthCare Pharmaceuticals, Inc.’s Yaz birth control drug causes strokes. In an order viewed by Law360, U.S. District Judge David R. Herndon said that Bayer had failed to properly conduct analyses or negotiations in certain cases alleging the drugs cause blood clots. He said that he believed that Bayer’s strategy was one of “attrition,” and that it amounted to “wearing everyone down over time.”

“An MDL judge certainly can and should be helpful to the litigation, part and parcel to the pretrial discovery by facilitating settlement, but when that settlement posture must come from wearing everyone down over time or expecting an entire group of catastrophically injured women, for the most part, to simply drop their claims, the MDL judge is not properly exercising his duties by simply standing by or dragging the pretrial proceedings out,” Judge Herndon said in his order.

The Plaintiff in the case alleges in her suit that she had a stroke after taking Yaz, and that Bayer should have been aware that drospirenone-containing contraceptives can cause heart problems, blood clots and strokes, among other things. Drospirenone is the synthetic hormone found in Yaz, according to Law360.

The MDL was organized in 2009 and grew to include as many as 12,000 suits at its peak. At the time, the Yaz MDL was the largest MDL in the country. In March 2013, Bayer agreed to pay $24 million to patients who alleged they developed gallbladder disease or had their gallbladders removed after using Yaz and Yasmin birth control pills, court documents obtained by Law360 show. The agreement allotted $3,000 to patients who had to have their gallbladders removed, and $2,000 to patients who developed gallbladder disease but did not have to have surgery. The total payout was to be capped at $24 million, and individual awards were to be reduced if the cap was exceeded.

The settlement did not resolve claims that Yaz and Yasmin caused patients to develop blood clots. disclaimer: This article: Federal Judge sets Yaz Birth Control Trial Date, Accuses Bayer of Trying to “Wear Everyone Down” was posted on Thursday, February 19th, 2015 at 3:21 pm at and is filed under Defective Drug Lawsuits.

« »

Comments are closed.